To explore the interplay between MET, E2F1, and purine synthesis in clinical cases of lung cancer, we stratified them based on different percentiles of high and low gene expression into groups of low (25th percentile) and high (75th percentile) expression. The gene discussed is MET; the disease is lung carcinoma.